Some of the signs might be worrying, but not for the obvious reasons

May 14, 2024 Latest News BioPharma Comment

This is a preview of subscriber content

Subscribe now to continue reading.

If the Budget includes the additional $3 billion and forecast spending on the pharmaceuticals function shows low, flat, or even declining growth, it probably also includes new PBS savings measures, whether or not they are announced. …

Subscribe now to continue reading.

Latest Video

Australia has 'all the ingredients' but has to decide what kind of health system it wants
November 26, 2025 - BioPharma
Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high
November 26, 2025 - Latest News
An interview that reminds us of the missing discussion in Australia
November 27, 2025 - Latest News
The US and UK edging closer to an agreement on pharmaceutical pricing
November 26, 2025 - Latest News
Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science
November 26, 2025 - Latest News

Some of the signs might be worrying, but not for the obvious reasons

This is a preview of subscriber content

Latest Video

Most Read

Australia has 'all the ingredients' but has to decide what kind of health system it wants

Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high

An interview that reminds us of the missing discussion in Australia

The US and UK edging closer to an agreement on pharmaceutical pricing

Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science

New Stories

Please stop falling this ridiculous trap, intentional or otherwise, it is not good

MSD to bring vaccine distribution back in-house after 40-year partnership with CSL Seqirus

Pharmac announces 90-day dispensed quantities of HIV medicines

Landmark report warns Australia’s hospital pharmacy system is at an 'inflection point'

Australia releases first national estimate of women living with metastatic breast cancer

Imugene and JW Therapeutics join forces on first-in-class combination for solid tumours

Algorae Pharmaceuticals secures new supply of chemotherapy for Australia through Dr Reddy’s partnership

Sign In

Some of the signs might be worrying, but not for the obvious reasons

This is a preview of subscriber content

Latest Video

Most Read

Australia has 'all the ingredients' but has to decide what kind of health system it wants

Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high

An interview that reminds us of the missing discussion in Australia

The US and UK edging closer to an agreement on pharmaceutical pricing

Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science

Follow Us

New Stories

Please stop falling this ridiculous trap, intentional or otherwise, it is not good

MSD to bring vaccine distribution back in-house after 40-year partnership with CSL Seqirus

Pharmac announces 90-day dispensed quantities of HIV medicines

Landmark report warns Australia’s hospital pharmacy system is at an 'inflection point'

Australia releases first national estimate of women living with metastatic breast cancer

Imugene and JW Therapeutics join forces on first-in-class combination for solid tumours

Algorae Pharmaceuticals secures new supply of chemotherapy for Australia through Dr Reddy’s partnership